Drug & medication recalls Moderate risk

Papaverine phentolamine prostaglandin recalled over sterility concerns

Recall date
January 15, 2016
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Abbott's Compounding Pharmacy, Inc. recalls papaverine phentolamine prostaglandin; 35/2.5 mg/1 mcg/mL, 10 mL, unit size, refrigerate, This Rx is Compounded, Abbott…
Recall number
D-0712-2016
FDA classification
Class II
Brand / firm
Abbott's Compounding Pharmacy, Inc.
Sold / distributed
CA

Why it was recalled

Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

papaverine phentolamine prostaglandin; 35/2.5 mg/1 mcg/mL, 10 mL, unit size, refrigerate, This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705

Get recall alerts

Free email alert whenever Abbott's Compounding Pharmacy, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Abbott's Compounding Pharmacy, Inc.